BRG-0451

N/A

Report date: 2022/04/18 14:06:57

Base Information

Drug NameBRG-0451
Drug Alias NameBRG-0451
ClassificationOther
Mechanisms of ActionUbiquitin-conjugating enzyme E2 K modulators
TargetsUbiquitin-conjugating enzyme E2 K
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBerg Llc
China Registration ClassN/A

Develop Information

Active CompaniesBerg Llc
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A